Alyssa Morris
Women's Health · Columbus, OHNPI 1245603422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $595, 9.7 times the $61 reported in 2021.
Across 84 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$361
- Astellas Pharma US Inc$290
- AbbVie$221
- Exact Sciences$157
- Agile Therapeutics, Inc.$102
- Exeltis, USA Inc.$78
- plus $532 from 17 others
What the payments were for
- Food & beverage$1,64194%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 17 | $361 |
| Astellas Pharma US Inc | 11 | $290 |
| AbbVie | 9 | $221 |
| Exact Sciences | 7 | $157 |
| Agile Therapeutics, Inc. | 6 | $102 |
| Exeltis, USA Inc. | 5 | $78 |
| Hologic Sales And Service, LLC | 3 | $56 |
| Organon | 4 | $55 |
| Shield Therapeutics Inc | 3 | $53 |
| Bayer | 3 | $49 |
| Coopersurgical, Inc. | 2 | $45 |
| Millicent US Inc | 2 | $34 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Gynesonics, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Octapharma USA, Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Biogen | 1 | $15 |
| Avanos Medical | 1 | $13 |
How this compares
$1,741 in reported general payments places this provider in the 85th percentile of 333 women's health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 69 | $5,879 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 16 | $2,414 |
| YuvafemEstradiol | 12 | $1,668 |
| ValacyclovirValacyclovir Hcl | 18 | $469 |
Paid to pharmacies, not to this prescriber.
Other women's health in Columbus
- Vivian RuszkiewiczColumbus$6K
- Georgia OwenColumbus$2K
- Brooke RengersColumbus$2K
- Kendal KingColumbus$2K
- Abigail NelsonColumbus$2K
- Jennifer BattagliaColumbus$2K
- Michelle RuszkiewiczColumbus$1K
- Rebecca SchmittColumbus$1K
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.